Alzheimers drugs rejected for use on the NHS: what happens now? @AlzheimersResearchUK
Alzheimers drugs rejected for use on the NHS: what happens now? @AlzheimersResearchUK
Uploaded June 2025 | Updated September 2026, 1 week ago
Lecanemab and donanemab, the first drugs shown to slow down the progression of Alzheimer's, have not met the criteria for the NHS. What does this mean for the future of dementia treatment and where do we go from here?
Alzheimers drugs rejected for use on the NHS: what happens now?Ed runs the London MarathonLessons from a lifetime: What decades of research reveal about dementia riskEarly signs of dementia - what you need to know | Alzheimers Research UK
Alzheimers Research UK |

Alzheimer's drugs rejected for use on the NHS: what happens now?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER